Company Spotlight

Recro

1300 Gould Drive
Gainesville, GA 30504
United States
View Profile

Cytovance Biologics

800 Research Pkwy., Suite 200
Oklahoma City, OK 73104
United States
View Profile

Biosynth Carbosynth

4 Rietlistrasse,
Staad, SG 9422
Switzerland
View Profile


Contract Service Directory


Toxikon





Company Headquarters

15 Wiggins Ave
Bedford, MA 01730
United States

Company Description

Toxikon is a leading preclinical contract research organization (CRO) providing in vivo, in vitro, and analytical testing services for the medical device, biotechnology, and pharmaceutical industries - helping those companies gain approval for their products quickly and bring them to market successfully.

Contract Service Directory

    Related Content

    • Clinical Trials | CRO News | Laboratory Testing | Toxicology
      Navigating a Competitive CRO Landscape

      Navigating a Competitive CRO Landscape

      Jacob McDonald of Lovelace Biomedical looks at consolidation in an increasingly competitive environment
      Jake McDonald, Ph.D., Chief Scientific Officer, Lovelace Biomedical 11.15.19

    • Analytical Services | Industry News | Laboratory Testing
      Sterigenics Acquires Toxikon’s European Lab Biz

      Sterigenics Acquires Toxikon’s European Lab Biz

      Acquisition creates leading extractables and leachables lab testing platform
      11.02.17

    • Breaking News | Drug Discovery | Validation

      Toxikon, Ocean Ridge Biosciences In Services Partnership

      To globally market respective discovery/development expertise
      10.27.11


    • Breaking News | Chemistry | CRO News | Industry News | Laboratory Testing | Preclinical Outsourcing

      Toxikon Expands ESRS

      Preclinical CRO begins construction on expanded Efficacy and Ssurgical Research Services wing
      Gil Roth 06.27.11

    • Breaking News | Promotions & Moves

      BASi

      BASi (Bioanalytical Systems Inc.) has added three representatives to its business development team.
      12.03.10

    • Breaking News | Drug Discovery | Industry News | Toxicology

      Toxikon Completes Tox Studies for Cellceutix

      Toxikon Corp. has completed toxicity studies in two species for Cellceutix Corp.’s Kevetrin, a compound in development for the treatment of resistant lung and breast cancers.
      11.03.10


    • Breaking News | Industry News | Toxicology

      Toxikon Adds Cancer Assay

      Toxikon has added the Comet Assay IV Analysis System developed by Perceptive Instruments to its genetic and molecular toxicology study offerings.
      09.02.10

    • Breaking News | Industry News | Toxicology

      Toxikon Expands Immunotoxicology Services

      Toxikon Corp. has expanded its immunotoxicology offerings, adding flow cyctometry, which enables the direct analysis of cells to detect a variety of specifically labeled components.
      09.22.09